{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:53:29Z","timestamp":1790924009354,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05773-x","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:28:15Z","timestamp":1790861295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging of mass-forming intrahepatic cholangiocarcinoma: from detection to personalized treatments"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-802X","authenticated-orcid":false,"given":"Cesare","family":"Maino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-3787","authenticated-orcid":false,"given":"Paolo Niccol\u00f2","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vizzuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Bazzocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-7047","authenticated-orcid":false,"given":"Davide","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Renzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-5936","authenticated-orcid":false,"given":"Riccardo","family":"Inchingolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"5773_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, et al (2023) Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34:127\u2013140. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.506","journal-title":"Ann Oncol"},{"key":"5773_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5773_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","volume":"23","author":"JM Banales","year":"2026","unstructured":"Banales JM, Rodrigues PM, Aff\u00f2 S, et al (2026) Cholangiocarcinoma 2026: status quo, unmet needs and priorities. Nat Rev Gastroenterol Hepatol 23:65\u201396. https:\/\/doi.org\/10.1038\/s41575-025-01153-w","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5773_CR4","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","volume":"76","author":"L Izquierdo-Sanchez","year":"2022","unstructured":"Izquierdo-Sanchez L, Lamarca A, La Casta A, et al (2022) Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol 76:1109\u20131121. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.010","journal-title":"J Hepatol"},{"key":"5773_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, et al (2021) Cholangiocarcinoma. Nat Rev Dis Primers 7:65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2","journal-title":"Nat Rev Dis Primers"},{"key":"5773_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.70357","author":"Y Muhammad","year":"2026","unstructured":"Muhammad Y, Jin Y, Luo K, et al (2026) Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy-A Comprehensive Review. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.70357","journal-title":"J Gastroenterol Hepatol"},{"key":"5773_CR7","doi-asserted-by":"publisher","first-page":"1321683","DOI":"10.3389\/fonc.2024.1321683","volume":"14","author":"SM Ruff","year":"2024","unstructured":"Ruff SM, Pawlik TM (2024) Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies. Front Oncol 14:1321683. https:\/\/doi.org\/10.3389\/fonc.2024.1321683","journal-title":"Front Oncol"},{"key":"5773_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-0040-1719188","volume":"37","author":"P Entezari","year":"2020","unstructured":"Entezari P, Riaz A (2020) Intrahepatic Cholangiocarcinoma. Semin Intervent Radiol 37:475\u2013483. https:\/\/doi.org\/10.1055\/s-0040-1719188","journal-title":"Semin Intervent Radiol"},{"key":"5773_CR9","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"D-Y Oh","year":"2022","unstructured":"Oh D-Y, Ruth He A, Qin S, et al (2022) Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evid 1:EVIDoa2200015. https:\/\/doi.org\/10.1056\/EVIDoa2200015","journal-title":"NEJM Evid"},{"key":"5773_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1470-2045(24)00082-2","volume":"25","author":"HA Burris","year":"2024","unstructured":"Burris HA, Okusaka T, Vogel A, et al (2024) Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 25:626\u2013635. https:\/\/doi.org\/10.1016\/S1470-2045(24)00082-2","journal-title":"Lancet Oncol"},{"key":"5773_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-004-0188-1","author":"BI Choi","year":"2004","unstructured":"Choi BI, Lee JM, Han JK (2004) Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging 29:. https:\/\/doi.org\/10.1007\/s00261-004-0188-1","journal-title":"Abdom Imaging"},{"key":"5773_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2214\/ajr.181.3.1810819","volume":"181","author":"JH Lim","year":"2003","unstructured":"Lim JH (2003) Cholangiocarcinoma: Morphologic Classification According to Growth Pattern and Imaging Findings. American Journal of Roentgenology 181:819\u2013827. https:\/\/doi.org\/10.2214\/ajr.181.3.1810819","journal-title":"American Journal of Roentgenology"},{"key":"5773_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1148\/radiol.2018171187","volume":"288","author":"I Joo","year":"2018","unstructured":"Joo I, Lee JM, Yoon JH (2018) Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 288:7\u201313. https:\/\/doi.org\/10.1148\/radiol.2018171187","journal-title":"Radiology"},{"key":"5773_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jhep.2025.03.007","volume":"83","author":"M Marzioni","year":"2025","unstructured":"Marzioni M, Maroni L, Aabakken L, et al (2025) EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma. Journal of Hepatology 83:211\u2013238. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.007","journal-title":"Journal of Hepatology"},{"key":"5773_CR15","doi-asserted-by":"publisher","first-page":"8548","DOI":"10.3390\/ijms24108548","volume":"24","author":"ME Ainora","year":"2023","unstructured":"Ainora ME, Cerrito L, Liguori A, et al (2023) Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors. IJMS 24:8548. https:\/\/doi.org\/10.3390\/ijms24108548","journal-title":"IJMS"},{"key":"5773_CR16","doi-asserted-by":"publisher","first-page":"20240005","DOI":"10.15557\/JoU.2024.0005","volume":"24","author":"G Gismondo Velardi","year":"2024","unstructured":"Gismondo Velardi G, Lico M, Teti A, et al (2024) Diagnosis of intrahepatic cholangiocarcinoma with CEUS. J Ultrason 24:20240005. https:\/\/doi.org\/10.15557\/JoU.2024.0005","journal-title":"J Ultrason"},{"key":"5773_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11604-020-01068-3","volume":"39","author":"SB Hong","year":"2021","unstructured":"Hong SB, Lee NK, Kim S, et al (2021) Structured reporting of CT or MRI for perihilar cholangiocarcinoma: usefulness for clinical planning and interdisciplinary communication. Jpn J Radiol 39:349\u2013356. https:\/\/doi.org\/10.1007\/s11604-020-01068-3","journal-title":"Jpn J Radiol"},{"key":"5773_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jmri.24810","volume":"42","author":"KS Jhaveri","year":"2015","unstructured":"Jhaveri KS, Hosseini-Nik H (2015) MRI of cholangiocarcinoma. Magnetic Resonance Imaging 42:1165\u20131179. https:\/\/doi.org\/10.1002\/jmri.24810","journal-title":"J Magn Reson Imaging"},{"key":"5773_CR19","doi-asserted-by":"publisher","first-page":"W64","DOI":"10.2214\/AJR.16.16923","volume":"209","author":"N Seo","year":"2017","unstructured":"Seo N, Kim DY, Choi J-Y (2017) Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis. American Journal of Roentgenology 209:W64\u2013W75. https:\/\/doi.org\/10.2214\/AJR.16.16923","journal-title":"American Journal of Roentgenology"},{"key":"5773_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/curroncol29020061","volume":"29","author":"JD Kova\u010d","year":"2022","unstructured":"Kova\u010d JD, Jankovi\u0107 A, \u0110iki\u0107-Rom A, et al (2022) Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI. Curr Oncol 29:698\u2013723. https:\/\/doi.org\/10.3390\/curroncol29020061","journal-title":"Curr Oncol"},{"key":"5773_CR21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s00261-014-0172-3","volume":"39","author":"N Al Ansari","year":"2014","unstructured":"Al Ansari N, Kim BS, Srirattanapong S, et al (2014) Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? Abdom Imaging 39:1228\u20131240. https:\/\/doi.org\/10.1007\/s00261-014-0172-3","journal-title":"Abdom Imaging"},{"key":"5773_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2214\/AJR.12.9488","volume":"201","author":"KJ Fowler","year":"2013","unstructured":"Fowler KJ, Sheybani A, Parker RA, et al (2013) Combined Hepatocellular and Cholangiocarcinoma (Biphenotypic) Tumors: Imaging Features and Diagnostic Accuracy of Contrast-Enhanced CT and MRI. American Journal of Roentgenology 201:332\u2013339. https:\/\/doi.org\/10.2214\/AJR.12.9488","journal-title":"American Journal of Roentgenology"},{"key":"5773_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40644-018-0142-z","volume":"18","author":"J Sammon","year":"2018","unstructured":"Sammon J, Fischer S, Menezes R, et al (2018) MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Cancer Imaging 18:8. https:\/\/doi.org\/10.1186\/s40644-018-0142-z","journal-title":"Cancer Imaging"},{"key":"5773_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1148\/radiol.2015142576","volume":"278","author":"V Vilgrain","year":"2016","unstructured":"Vilgrain V, Lagadec M, Ronot M (2016) Pitfalls in Liver Imaging. Radiology 278:34\u201351. https:\/\/doi.org\/10.1148\/radiol.2015142576","journal-title":"Radiology"},{"key":"5773_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.diii.2013.04.008","volume":"94","author":"T Klotz","year":"2013","unstructured":"Klotz T, Montoriol P-F, Da Ines D, et al (2013) Hepatic haemangioma: Common and uncommon imaging features. Diagnostic and Interventional Imaging 94:849\u2013859. https:\/\/doi.org\/10.1016\/j.diii.2013.04.008","journal-title":"Diagnostic and Interventional Imaging"},{"key":"5773_CR26","first-page":"554","volume":"82","author":"M Renzulli","year":"2019","unstructured":"Renzulli M, Capozzi N, Clemente A, et al (2019) What happened to my liver lesion (Hepatic Sclerosed Hemangioma)? Let\u2019s not forget (radiological) history. Acta Gastroenterol Belg 82:554\u2013555","journal-title":"Acta Gastroenterol Belg"},{"key":"5773_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1148\/rg.2016150196","volume":"36","author":"P B\u00e4chler","year":"2016","unstructured":"B\u00e4chler P, Baladron MJ, Menias C, et al (2016) Multimodality Imaging of Liver Infections: Differential Diagnosis and Potential Pitfalls. Radiographics 36:1001\u20131023. https:\/\/doi.org\/10.1148\/rg.2016150196","journal-title":"Radiographics"},{"key":"5773_CR28","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/hep4.1774","volume":"5","author":"Y-Y Kim","year":"2021","unstructured":"Kim Y-Y, Yeom S-K, Shin H, et al (2021) Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging. Hepatol Commun 5:2009\u20132018. https:\/\/doi.org\/10.1002\/hep4.1774","journal-title":"Hepatol Commun"},{"key":"5773_CR29","doi-asserted-by":"publisher","first-page":"e98612","DOI":"10.1371\/journal.pone.0098612","volume":"9","author":"R Li","year":"2014","unstructured":"Li R, Yuan M-X, Ma K, et al (2014) Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis. PLoS One 9:e98612. https:\/\/doi.org\/10.1371\/journal.pone.0098612","journal-title":"PLoS One"},{"key":"5773_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00261-023-04064-z","volume":"49","author":"Y Wu","year":"2024","unstructured":"Wu Y, Xia C, Chen J, et al (2024) Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis. Abdom Radiol (NY) 49:34\u201348. https:\/\/doi.org\/10.1007\/s00261-023-04064-z","journal-title":"Abdom Radiol (NY)"},{"key":"5773_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver (2023) EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 79:181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010","journal-title":"J Hepatol"},{"key":"5773_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jso.23605","volume":"110","author":"N Amini","year":"2014","unstructured":"Amini N, Ejaz A, Spolverato G, et al (2014) Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol 110:163\u2013170. https:\/\/doi.org\/10.1002\/jso.23605","journal-title":"J Surg Oncol"},{"key":"5773_CR33","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383:2168\u20132179. https:\/\/doi.org\/10.1016\/S0140-6736(13)61903-0","journal-title":"Lancet"},{"key":"5773_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00261-024-04216-9","volume":"50","author":"AS Kierans","year":"2025","unstructured":"Kierans AS, Costello J, Qayyum A, et al (2025) Imaging cholangiocarcinoma: CT and MRI techniques. Abdom Radiol (NY) 50:94\u2013108. https:\/\/doi.org\/10.1007\/s00261-024-04216-9","journal-title":"Abdom Radiol (NY)"},{"key":"5773_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RLU.0b013e3182867b99","volume":"39","author":"TG Park","year":"2014","unstructured":"Park TG, Yu Y-D, Park BJ, et al (2014) Implication of lymph node metastasis detected on 18F-FDG PET\/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma. Clin Nucl Med 39:1\u20137. https:\/\/doi.org\/10.1097\/RLU.0b013e3182867b99","journal-title":"Clin Nucl Med"},{"key":"5773_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, et al (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72:364\u2013377. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.020","journal-title":"J Hepatol"},{"key":"5773_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000364836","volume":"31","author":"KP Cieslak","year":"2014","unstructured":"Cieslak KP, Runge JH, Heger M, et al (2014) New perspectives in the assessment of future remnant liver. Dig Surg 31:255\u2013268. https:\/\/doi.org\/10.1159\/000364836","journal-title":"Dig Surg"},{"key":"5773_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/jso.27396","volume":"128","author":"H Shahbazian","year":"2023","unstructured":"Shahbazian H, Mirza-Aghazadeh-Attari M, Borhani A, et al (2023) Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Surg Oncol 128:519\u2013530. https:\/\/doi.org\/10.1002\/jso.27396","journal-title":"J Surg Oncol"},{"key":"5773_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00261-001-0094-8","volume":"27","author":"A Blachar","year":"2002","unstructured":"Blachar A, Federle MP, Brancatelli G (2002) Hepatic capsular retraction: spectrum of benign and malignant etiologies. Abdom Imaging 27:690\u2013699. https:\/\/doi.org\/10.1007\/s00261-001-0094-8","journal-title":"Abdom Imaging"},{"key":"5773_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","volume":"17","author":"SM Weber","year":"2015","unstructured":"Weber SM, Ribero D, O\u2019Reilly EM, et al (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17:669\u2013680. https:\/\/doi.org\/10.1111\/hpb.12441","journal-title":"HPB (Oxford)"},{"key":"5773_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.23736\/S2724-5691.22.09541-7","volume":"77","author":"G Cassese","year":"2022","unstructured":"Cassese G, Han H-S, Al Farai A, et al (2022) Future remnant liver optimization: preoperative assessment, volume augmentation procedures and management of PVE failure. Minerva Surg 77:368\u2013379. https:\/\/doi.org\/10.23736\/S2724-5691.22.09541-7","journal-title":"Minerva Surg"},{"key":"5773_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2214\/AJR.14.12830","volume":"204","author":"MR Engelbrecht","year":"2015","unstructured":"Engelbrecht MR, Katz SS, van Gulik TM, et al (2015) Imaging of perihilar cholangiocarcinoma. AJR Am J Roentgenol 204:782\u2013791. https:\/\/doi.org\/10.2214\/AJR.14.12830","journal-title":"AJR Am J Roentgenol"},{"key":"5773_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000453009","volume":"32","author":"S-C Olthof","year":"2016","unstructured":"Olthof S-C, Othman A, Clasen S, et al (2016) Imaging of Cholangiocarcinoma. Visc Med 32:402\u2013410. https:\/\/doi.org\/10.1159\/000453009","journal-title":"Visc Med"},{"key":"5773_CR44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3348\/kjr.2023.0368","volume":"24","author":"J Yoo","year":"2023","unstructured":"Yoo J, Lee JM, Kang H-J, et al (2023) Comparison Between Contrast-Enhanced Computed Tomography and Contrast-Enhanced Magnetic Resonance Imaging With Magnetic Resonance Cholangiopancreatography for Resectability Assessment in Extrahepatic Cholangiocarcinoma. Korean J Radiol 24:983\u2013995. https:\/\/doi.org\/10.3348\/kjr.2023.0368","journal-title":"Korean J Radiol"},{"key":"5773_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40792-020-01085-4","volume":"7","author":"G Hamano","year":"2021","unstructured":"Hamano G, Takemura S, Tanaka S, et al (2021) Intrahepatic cholangiocarcinoma with a tumor thrombus extending from the inferior vena cava to the right atrium: a case report. Surg Case Rep 7:3. https:\/\/doi.org\/10.1186\/s40792-020-01085-4","journal-title":"Surg Case Rep"},{"key":"5773_CR46","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00330-020-07282-x","volume":"31","author":"DH Kim","year":"2021","unstructured":"Kim DH, Choi SH, Park SH, et al (2021) The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis. Eur Radiol 31:2497\u20132506. https:\/\/doi.org\/10.1007\/s00330-020-07282-x","journal-title":"Eur Radiol"},{"key":"5773_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1148\/radiol.2383050419","volume":"239","author":"HY Lee","year":"2006","unstructured":"Lee HY, Kim SH, Lee JM, et al (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113\u2013121. https:\/\/doi.org\/10.1148\/radiol.2383050419","journal-title":"Radiology"},{"key":"5773_CR48","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.21037\/qims-20-1303","volume":"11","author":"LC Franken","year":"2021","unstructured":"Franken LC, Coelen RJS, Erdmann JI, et al (2021) Multidetector computed tomography assessment of vascular involvement in perihilar cholangiocarcinoma. Quant Imaging Med Surg 11:4514\u20134521. https:\/\/doi.org\/10.21037\/qims-20-1303","journal-title":"Quant Imaging Med Surg"},{"key":"5773_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jso.24633","volume":"116","author":"BN Reames","year":"2017","unstructured":"Reames BN, Ejaz A, Koerkamp BG, et al (2017) Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis. J Surg Oncol 116:133\u2013139. https:\/\/doi.org\/10.1002\/jso.24633","journal-title":"J Surg Oncol"},{"key":"5773_CR50","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3390\/jcm10112426","volume":"10","author":"F Bartsch","year":"2021","unstructured":"Bartsch F, Heuft L-K, Baumgart J, et al (2021) Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma. J Clin Med 10:2426. https:\/\/doi.org\/10.3390\/jcm10112426","journal-title":"J Clin Med"},{"key":"5773_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000449339","volume":"5","author":"T Yoh","year":"2016","unstructured":"Yoh T, Hatano E, Yamanaka K, et al (2016) Is Surgical Resection Justified for Advanced Intrahepatic Cholangiocarcinoma? Liver Cancer 5:280\u2013289. https:\/\/doi.org\/10.1159\/000449339","journal-title":"Liver Cancer"},{"key":"5773_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1159\/000493434","volume":"36","author":"Y Tomimaru","year":"2019","unstructured":"Tomimaru Y, Eguchi H, Wada H, et al (2019) Surgical Outcomes of Liver Resection Combined with Inferior Vena Cava Resection and Reconstruction with Artificial Vascular Graft. Dig Surg 36:502\u2013508. https:\/\/doi.org\/10.1159\/000493434","journal-title":"Dig Surg"},{"key":"5773_CR53","doi-asserted-by":"publisher","first-page":"44521","DOI":"10.18632\/oncotarget.17815","volume":"8","author":"A Si","year":"2017","unstructured":"Si A, Li J, Xiang H, et al (2017) Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma. Oncotarget 8:44521\u201344532. https:\/\/doi.org\/10.18632\/oncotarget.17815","journal-title":"Oncotarget"},{"key":"5773_CR54","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12876-018-0912-x","volume":"18","author":"K-M Chan","year":"2018","unstructured":"Chan K-M, Tsai C-Y, Yeh C-N, et al (2018) Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterol 18:180. https:\/\/doi.org\/10.1186\/s12876-018-0912-x","journal-title":"BMC Gastroenterol"},{"key":"5773_CR55","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1148\/radiol.12112308","volume":"264","author":"Y Kang","year":"2012","unstructured":"Kang Y, Lee JM, Kim SH, et al (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751\u2013760. https:\/\/doi.org\/10.1148\/radiol.12112308","journal-title":"Radiology"},{"key":"5773_CR56","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1007\/s11605-021-04911-8","volume":"25","author":"TL Sutton","year":"2021","unstructured":"Sutton TL, Billingsley KG, Walker BS, et al (2021) Detection of Tumor Multifocality in Resectable Intrahepatic Cholangiocarcinoma: Defining the Optimal Pre-operative Imaging Modality. J Gastrointest Surg 25:2250\u20132257. https:\/\/doi.org\/10.1007\/s11605-021-04911-8","journal-title":"J Gastrointest Surg"},{"key":"5773_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/hbsn.2016.12.10","volume":"6","author":"K F\u00e1brega-Foster","year":"2017","unstructured":"F\u00e1brega-Foster K, Ghasabeh MA, Pawlik TM, Kamel IR (2017) Multimodality imaging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 6:67\u201378. https:\/\/doi.org\/10.21037\/hbsn.2016.12.10","journal-title":"Hepatobiliary Surg Nutr"},{"key":"5773_CR58","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejso.2019.11.502","volume":"46","author":"M Moustafa","year":"2020","unstructured":"Moustafa M, Fasolo E, Bassi D, et al (2020) The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis. Eur J Surg Oncol 46:632\u2013637. https:\/\/doi.org\/10.1016\/j.ejso.2019.11.502","journal-title":"Eur J Surg Oncol"},{"key":"5773_CR59","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11605-019-04184-2","volume":"23","author":"S Buettner","year":"2019","unstructured":"Buettner S, Ten Cate DWG, Bagante F, et al (2019) Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 23:2239\u20132246. https:\/\/doi.org\/10.1007\/s11605-019-04184-2","journal-title":"J Gastrointest Surg"},{"key":"5773_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1245\/s10434-017-6110-1","volume":"25","author":"GP Wright","year":"2018","unstructured":"Wright GP, Perkins S, Jones H, et al (2018) Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies. Ann Surg Oncol 25:83\u201390. https:\/\/doi.org\/10.1245\/s10434-017-6110-1","journal-title":"Ann Surg Oncol"},{"key":"5773_CR61","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1245\/s10434-014-4223-3","volume":"22","author":"G Spolverato","year":"2015","unstructured":"Spolverato G, Kim Y, Alexandrescu S, et al (2015) Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Ann Surg Oncol 22:2218\u20132225. https:\/\/doi.org\/10.1245\/s10434-014-4223-3","journal-title":"Ann Surg Oncol"},{"key":"5773_CR62","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1245\/s10434-019-08192-z","volume":"27","author":"J Li","year":"2020","unstructured":"Li J, Moustafa M, Linecker M, et al (2020) ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study. Ann Surg Oncol 27:1372\u20131384. https:\/\/doi.org\/10.1245\/s10434-019-08192-z","journal-title":"Ann Surg Oncol"},{"key":"5773_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","volume":"71","author":"A Lamarca","year":"2019","unstructured":"Lamarca A, Barriuso J, Chander A, et al (2019) 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. J Hepatol 71:115\u2013129. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.038","journal-title":"J Hepatol"},{"key":"5773_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00432-025-06342-3","volume":"151","author":"A Schindler","year":"2025","unstructured":"Schindler A, Denecke T, Seehofer D, et al (2025) Intrahepatic cholangiocarcinoma as a unique subtype: key updates from current guidelines. J Cancer Res Clin Oncol 151:305. https:\/\/doi.org\/10.1007\/s00432-025-06342-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"5773_CR65","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.3390\/cancers15194691","volume":"15","author":"D Moris","year":"2023","unstructured":"Moris D (2023) Surgical Management of Intrahepatic Cholangiocarcinoma: Quo Vadis. Cancers (Basel) 15:4691. https:\/\/doi.org\/10.3390\/cancers15194691","journal-title":"Cancers (Basel)"},{"key":"5773_CR66","first-page":"584","volume":"21","author":"J O\u2019Bryan","year":"2023","unstructured":"O\u2019Bryan J, Sadagopan N, Winslow E, et al (2023) Surgical resection criteria and neoadjuvant therapies for intrahepatic cholangiocarcinoma. Clin Adv Hematol Oncol 21:584\u2013591","journal-title":"Clin Adv Hematol Oncol"},{"key":"5773_CR67","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1245\/s10434-025-17776-x","volume":"32","author":"J Kawashima","year":"2025","unstructured":"Kawashima J, Akabane M, Woldesenbet S, et al (2025) Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary Management. Ann Surg Oncol 32:7141\u20137151. https:\/\/doi.org\/10.1245\/s10434-025-17776-x","journal-title":"Ann Surg Oncol"},{"key":"5773_CR68","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1148\/rg.220050","volume":"42","author":"P Entezari","year":"2022","unstructured":"Entezari P, Toskich BB, Kim E, et al (2022) Promoting Surgical Resection through Future Liver Remnant Hypertrophy. Radiographics 42:2166\u20132183. https:\/\/doi.org\/10.1148\/rg.220050","journal-title":"Radiographics"},{"key":"5773_CR69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-2008-1076684","volume":"25","author":"DA Anaya","year":"2008","unstructured":"Anaya DA, Blazer DG, Abdalla EK (2008) Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol 25:110\u2013122. https:\/\/doi.org\/10.1055\/s-2008-1076684","journal-title":"Semin Intervent Radiol"},{"key":"5773_CR70","doi-asserted-by":"publisher","first-page":"347","DOI":"10.35772\/ghm.2025.01102","volume":"7","author":"L Chen","year":"2025","unstructured":"Chen L, Han R, Song T, et al (2025) Perioperative and precision strategies in resectable intrahepatic cholangiocarcinoma. Glob Health Med 7:347\u2013351. https:\/\/doi.org\/10.35772\/ghm.2025.01102","journal-title":"Glob Health Med"},{"key":"5773_CR71","doi-asserted-by":"publisher","first-page":"107100","DOI":"10.1016\/j.ejso.2023.107100","volume":"49","author":"N Nevermann","year":"2023","unstructured":"Nevermann N, Bode J, Vischer M, et al (2023) Perioperative outcome and long-term survival for intrahepatic cholangiocarcinoma after portal vein embolization and subsequent resection: A propensity-matched study. Eur J Surg Oncol 49:107100. https:\/\/doi.org\/10.1016\/j.ejso.2023.107100","journal-title":"Eur J Surg Oncol"},{"key":"5773_CR72","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","volume":"45","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45:856\u2013867. https:\/\/doi.org\/10.1016\/j.jhep.2006.09.001","journal-title":"J Hepatol"},{"key":"5773_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/hep-2017-0005","volume":"4","author":"O Akinwande","year":"2017","unstructured":"Akinwande O, Shah V, Mills A, et al (2017) Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicity. Hepat Oncol 4:75\u201381. https:\/\/doi.org\/10.2217\/hep-2017-0005","journal-title":"Hepat Oncol"},{"key":"5773_CR74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, et al (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157","journal-title":"Nat Rev Clin Oncol"},{"key":"5773_CR75","doi-asserted-by":"publisher","first-page":"1204717","DOI":"10.3389\/fmed.2023.1204717","volume":"10","author":"C Nanni","year":"2023","unstructured":"Nanni C, Mosconi C, Dragonetti V, et al (2023) Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma. Front Med (Lausanne) 10:1204717. https:\/\/doi.org\/10.3389\/fmed.2023.1204717","journal-title":"Front Med (Lausanne)"},{"key":"5773_CR76","doi-asserted-by":"publisher","first-page":"1270264","DOI":"10.3389\/fgstr.2023.1270264","volume":"2","author":"MA Cocozza","year":"2023","unstructured":"Cocozza MA, Braccischi L, De Cinque A, et al (2023) Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose? Front Gastroenterol (Lausanne) 2:1270264. https:\/\/doi.org\/10.3389\/fgstr.2023.1270264","journal-title":"Front Gastroenterol (Lausanne)"},{"key":"5773_CR77","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1186\/s12885-017-3788-1","volume":"17","author":"E Gkika","year":"2017","unstructured":"Gkika E, Hallauer L, Kirste S, et al (2017) Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. BMC Cancer 17:781. https:\/\/doi.org\/10.1186\/s12885-017-3788-1","journal-title":"BMC Cancer"},{"key":"5773_CR78","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/egh.12.20","volume":"6","author":"V Valero","year":"2012","unstructured":"Valero V, Cosgrove D, Herman JM, Pawlik TM (2012) Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol 6:481\u2013495. https:\/\/doi.org\/10.1586\/egh.12.20","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5773_CR79","doi-asserted-by":"publisher","first-page":"996710","DOI":"10.3389\/fonc.2022.996710","volume":"12","author":"AA Connor","year":"2022","unstructured":"Connor AA, Kodali S, Abdelrahim M, et al (2022) Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers. Front Oncol 12:996710. https:\/\/doi.org\/10.3389\/fonc.2022.996710","journal-title":"Front Oncol"},{"key":"5773_CR80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21037\/hbsn.2017.01.16","volume":"6","author":"EJ Koay","year":"2017","unstructured":"Koay EJ, Odisio BC, Javle M, et al (2017) Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments? Hepatobiliary Surg Nutr 6:105\u2013116. https:\/\/doi.org\/10.21037\/hbsn.2017.01.16","journal-title":"Hepatobiliary Surg Nutr"},{"key":"5773_CR81","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.4254\/wjh.v15.i12.1284","volume":"15","author":"A Elvevi","year":"2023","unstructured":"Elvevi A, Laffusa A, Elisei F, et al (2023) Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? World J Hepatol 15:1284\u20131293. https:\/\/doi.org\/10.4254\/wjh.v15.i12.1284","journal-title":"World J Hepatol"},{"key":"5773_CR82","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","volume":"8","author":"T Patel","year":"2011","unstructured":"Patel T (2011) Cholangiocarcinoma\u2013controversies and challenges. Nat Rev Gastroenterol Hepatol 8:189\u2013200. https:\/\/doi.org\/10.1038\/nrgastro.2011.20","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5773_CR83","doi-asserted-by":"publisher","first-page":"46750","DOI":"10.18632\/oncotarget.8775","volume":"7","author":"DQ Chong","year":"2016","unstructured":"Chong DQ, Zhu AX (2016) The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. Oncotarget 7:46750\u201346767. https:\/\/doi.org\/10.18632\/oncotarget.8775","journal-title":"Oncotarget"},{"key":"5773_CR84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5582\/irdr.2022.01109","volume":"11","author":"X Zhang","year":"2022","unstructured":"Zhang X, Cai Y, Xiong X, et al (2022) Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update. Intractable Rare Dis Res 11:161\u2013172. https:\/\/doi.org\/10.5582\/irdr.2022.01109","journal-title":"Intractable Rare Dis Res"},{"key":"5773_CR85","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.soc.2019.06.013","volume":"28","author":"BL Green","year":"2019","unstructured":"Green BL, House MG (2019) Nonsurgical Approaches to Treat Biliary Tract and Liver Tumors. Surg Oncol Clin N Am 28:573\u2013586. https:\/\/doi.org\/10.1016\/j.soc.2019.06.013","journal-title":"Surg Oncol Clin N Am"},{"key":"5773_CR86","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41575-020-0314-8","volume":"17","author":"H Petrowsky","year":"2020","unstructured":"Petrowsky H, Fritsch R, Guckenberger M, et al (2020) Modern therapeutic approaches for the treatment of malignant liver tumours. Nat Rev Gastroenterol Hepatol 17:755\u2013772. https:\/\/doi.org\/10.1038\/s41575-020-0314-8","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5773_CR87","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/medicina59040729","volume":"59","author":"MP Wasilewicz","year":"2023","unstructured":"Wasilewicz MP, Becht R (2023) Intrahepatic Cholangiocarcinoma-Where Are We Now and Where Are We Going to? Medicina (Kaunas) 59:729. https:\/\/doi.org\/10.3390\/medicina59040729","journal-title":"Medicina (Kaunas)"},{"key":"5773_CR88","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00330-024-11006-w","volume":"35","author":"GA Zamboni","year":"2025","unstructured":"Zamboni GA, Cappello G, Caruso D, et al (2025) ESR Essentials: response assessment criteria in oncologic imaging-practice recommendations by the European Society of Oncologic Imaging. Eur Radiol 35:674\u2013683. https:\/\/doi.org\/10.1007\/s00330-024-11006-w","journal-title":"Eur Radiol"},{"key":"5773_CR89","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jvir.2013.10.056","volume":"25","author":"JC Camacho","year":"2014","unstructured":"Camacho JC, Kokabi N, Xing M, et al (2014) Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization. J Vasc Interv Radiol 25:256\u2013265. https:\/\/doi.org\/10.1016\/j.jvir.2013.10.056","journal-title":"J Vasc Interv Radiol"},{"key":"5773_CR90","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1148\/radiol.2018171593","volume":"288","author":"A Pandey","year":"2018","unstructured":"Pandey A, Pandey P, Aliyari Ghasabeh M, et al (2018) Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival. Radiology 288:109\u2013117. https:\/\/doi.org\/10.1148\/radiol.2018171593","journal-title":"Radiology"},{"key":"5773_CR91","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5306\/wjco.v12.i5.323","volume":"12","author":"D Ippolito","year":"2021","unstructured":"Ippolito D, Maino C, Ragusi M, et al (2021) Immune response evaluation criteria in solid tumors for assessment of atypical responses after immunotherapy. World J Clin Oncol 12:323\u2013334. https:\/\/doi.org\/10.5306\/wjco.v12.i5.323","journal-title":"World J Clin Oncol"},{"key":"5773_CR92","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1148\/radiol.12112142","volume":"264","author":"VG Halappa","year":"2012","unstructured":"Halappa VG, Bonekamp S, Corona-Villalobos CP, et al (2012) Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology 264:285\u2013294. https:\/\/doi.org\/10.1148\/radiol.12112142","journal-title":"Radiology"},{"key":"5773_CR93","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1245\/s10434-019-07353-4","volume":"26","author":"L-S Hu","year":"2019","unstructured":"Hu L-S, Zhang X-F, Weiss M, et al (2019) Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 26:2549\u20132557. https:\/\/doi.org\/10.1245\/s10434-019-07353-4","journal-title":"Ann Surg Oncol"},{"key":"5773_CR94","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00261-018-1727-5","volume":"44","author":"S Kim","year":"2019","unstructured":"Kim S, An C, Han K, Kim M-J (2019) Gadoxetic acid enhanced magnetic resonance imaging for prediction of the postoperative prognosis of intrahepatic mass-forming cholangiocarcinoma. Abdom Radiol (NY) 44:110\u2013121. https:\/\/doi.org\/10.1007\/s00261-018-1727-5","journal-title":"Abdom Radiol (NY)"},{"key":"5773_CR95","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.3390\/cancers15082384","volume":"15","author":"M Owen","year":"2023","unstructured":"Owen M, Makary MS, Beal EW (2023) Locoregional Therapy for Intrahepatic Cholangiocarcinoma. Cancers (Basel) 15:2384. https:\/\/doi.org\/10.3390\/cancers15082384","journal-title":"Cancers (Basel)"},{"key":"5773_CR96","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiol.2018180450","volume":"289","author":"A Pandey","year":"2018","unstructured":"Pandey A, Pandey P, Ghasabeh MA, et al (2018) Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization? Radiology 289:843\u2013853. https:\/\/doi.org\/10.1148\/radiol.2018180450","journal-title":"Radiology"},{"key":"5773_CR97","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/bjc.2016.191","volume":"115","author":"C Mosconi","year":"2016","unstructured":"Mosconi C, Gramenzi A, Ascanio S, et al (2016) Yttrium-90 radioembolization for unresectable\/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study. Br J Cancer 115:297\u2013302. https:\/\/doi.org\/10.1038\/bjc.2016.191","journal-title":"Br J Cancer"},{"key":"5773_CR98","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jvir.2020.02.008","volume":"31","author":"S Buettner","year":"2020","unstructured":"Buettner S, Braat AJAT, Margonis GA, et al (2020) Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis. J Vasc Interv Radiol 31:1035\u20131043.e2. https:\/\/doi.org\/10.1016\/j.jvir.2020.02.008","journal-title":"J Vasc Interv Radiol"},{"key":"5773_CR99","doi-asserted-by":"publisher","first-page":"307","DOI":"10.21037\/qims-2025-1242","volume":"16","author":"A Bassir","year":"2026","unstructured":"Bassir A, Dang C, Chiu K, et al (2026) 99mTc MAA SPECT\/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following 90Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD). Quant Imaging Med Surg 16:307. https:\/\/doi.org\/10.21037\/qims-2025-1242","journal-title":"Quant Imaging Med Surg"},{"key":"5773_CR100","doi-asserted-by":"publisher","first-page":"126245","DOI":"10.1155\/2015\/126245","volume":"2015","author":"OR Brook","year":"2015","unstructured":"Brook OR, Thornton E, Mendiratta-Lala M, et al (2015) CT Imaging Findings after Stereotactic Radiotherapy for Liver Tumors. Gastroenterol Res Pract 2015:126245. https:\/\/doi.org\/10.1155\/2015\/126245","journal-title":"Gastroenterol Res Pract"},{"key":"5773_CR101","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1148\/rg.220084","volume":"42","author":"PJ Navin","year":"2022","unstructured":"Navin PJ, Olson MC, Mendiratta-Lala M, et al (2022) Imaging Features in the Liver after Stereotactic Body Radiation Therapy. Radiographics 42:2131\u20132148. https:\/\/doi.org\/10.1148\/rg.220084","journal-title":"Radiographics"},{"key":"5773_CR102","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/PAS.0000000000002052","volume":"47","author":"GST Soon","year":"2023","unstructured":"Soon GST, Yasir S, Wu T-T, et al (2023) Unique Morphologic Findings in the Liver After Stereotactic Radiation for Cholangiocarcinoma. Am J Surg Pathol 47:792\u2013800. https:\/\/doi.org\/10.1097\/PAS.0000000000002052","journal-title":"Am J Surg Pathol"},{"key":"5773_CR103","doi-asserted-by":"publisher","first-page":"1225154","DOI":"10.3389\/fonc.2023.1225154","volume":"13","author":"H Taghizadeh","year":"2023","unstructured":"Taghizadeh H, Djanani A, Eisterer W, et al (2023) Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement. Front Oncol 13:1225154. https:\/\/doi.org\/10.3389\/fonc.2023.1225154","journal-title":"Front Oncol"},{"key":"5773_CR104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40644-023-00580-9","volume":"23","author":"S M\u00f6nch","year":"2023","unstructured":"M\u00f6nch S, Heimer MM, Winkelmann M, et al (2023) Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors. Cancer Imaging 23:58. https:\/\/doi.org\/10.1186\/s40644-023-00580-9","journal-title":"Cancer Imaging"},{"key":"5773_CR105","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/jpm14121143","volume":"14","author":"S Ursprung","year":"2024","unstructured":"Ursprung S, Thaiss W, Beha J, et al (2024) Standardized Response Assessment in Patients with Advanced Cholangiocarcinoma Treated with Personalized Therapy. J Pers Med 14:1143. https:\/\/doi.org\/10.3390\/jpm14121143","journal-title":"J Pers Med"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05773-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:01:44Z","timestamp":1790920904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":105,"alternative-id":["5773"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05773-x","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Davide Ippolito is Associate Editor of Abdominal Radiology (section: Hepatopancreaticobiliary & Spleen); Cesare Maino is Junior Deputy Editor of European Radiology.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}